“We have made a lot of progress in our ability to help cancer patients overcome and live with their disease. Most of this progress has been driven by earlier and more accurate diagnoses, which allows doctors to better tailor the treatment to an individual patient’s disease.”

Professor Manon van Engeland



“Epigenetic events are driving a significant proportion of cancer cases and are still underutilized for the earlier detection of disease and disease relapse. By joining forces between academia and industry through Epify we aim to make an impactful contribution towards improving patients’ outlooks.”

Professor Wim Van Criekinge